BRANCHBURG, N.J., Dec. 19 /PRNewswire-FirstCall/ -- LifeCell Corporation (Nasdaq: LIFC), today announced plans to release preliminary fourth quarter 2007 revenues and 2008 financial guidance on Monday, January 7, 2008 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company's fourth quarter 2007 revenues and expected financial performance for 2008.
The dial-in number for the live call is (888) 211-7292/domestic or (913) 981-4902/international. A simultaneous webcast of the call will be available via LifeCell's website at http://www.lifecell.com Corporate Information - Investor Relations. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available through January 12, 2008. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457- 0820. The replay access code is 8968654.
LifeCell develops and markets innovative biologically-based products in
the emerging field of regenerative medicine for use in reconstructive,
orthopedic and urogynecologic surgical procedures. LifeCell's current
marketed products include: ALLODERM(R) regenerative tissue matrix, for
plastic reconstructive, general surgical, burn and periodontal procedures;
CYMETRA(R) (Micronized AlloDerm(R)), a particulate form of ALLODERM(R)
suitable for injection; GRAFTJACKET(R) regenerative tissue matrix, for
orthopedic applications and lower extremity wounds; ALLOCRAFT(R)DBM, for
bone grafting procedures; and REPLIFORM(R) tissue regeneration matrix for
urogynecologic surgical procedures. The Company's research and development
|SOURCE LifeCell Corporation|
Copyright©2007 PR Newswire.
All rights reserved